Effect on Hepatitis C Virus Replication of Combinations of Direct-Acting Antivirals, Including NS5A Inhibitor Daclatasvir
出版年份 2012 全文链接
标题
Effect on Hepatitis C Virus Replication of Combinations of Direct-Acting Antivirals, Including NS5A Inhibitor Daclatasvir
作者
关键词
-
出版物
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 56, Issue 10, Pages 5230-5239
出版商
American Society for Microbiology
发表日期
2012-07-31
DOI
10.1128/aac.01209-12
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Single- and Multiple-Ascending-Dose Studies of the NS3 Protease Inhibitor Asunaprevir in Subjects with or without Chronic Hepatitis C
- (2012) Claudio Pasquinelli et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Resistance Analysis of the Hepatitis C Virus NS3 Protease Inhibitor Asunaprevir
- (2012) Fiona McPhee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antiviral strategies in hepatitis C virus infection
- (2012) Christoph Sarrazin et al. JOURNAL OF HEPATOLOGY
- Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1
- (2012) Anna S. Lok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Boceprevir: A Protease Inhibitor for the Treatment of Chronic Hepatitis C
- (2011) Bryce S Foote et al. ANNALS OF PHARMACOTHERAPY
- Syntheses and initial evaluation of a series of indolo-fused heterocyclic inhibitors of the polymerase enzyme (NS5B) of the hepatitis C virus
- (2011) Xiaofan Zheng et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Multiple ascending dose study of BMS-790052, a nonstructural protein 5A replication complex inhibitor, in patients infected with hepatitis C virus genotype 1
- (2011) Richard E. Nettles et al. HEPATOLOGY
- Genotypic and phenotypic analysis of variants resistant to hepatitis C virus nonstructural protein 5A replication complex inhibitor BMS-790052 in Humans: In Vitro and In Vivo Correlations
- (2011) Robert A. Fridell et al. HEPATOLOGY
- Boceprevir for Untreated Chronic HCV Genotype 1 Infection
- (2011) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
- (2011) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Resistance Analysis of the Hepatitis C Virus NS5A Inhibitor BMS-790052 in an In Vitro Replicon System
- (2010) R. A. Fridell et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Resistance Profile of the Hepatitis C Virus NS3/4A Protease Inhibitor TMC435
- (2010) O. Lenz et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- New NS5B polymerase inhibitors for hepatitis C
- (2010) Florence Legrand-Abravanel et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Elimination of hepatitis C virus by short term NS3-4A and NS5B inhibitor combination therapy in human hepatocyte chimeric mice
- (2010) Eiji Ohara et al. JOURNAL OF HEPATOLOGY
- Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial
- (2010) Edward J Gane et al. LANCET
- Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect
- (2010) Min Gao et al. NATURE
- Drug resistance against HCV NS3/4A inhibitors is defined by the balance of substrate recognition versus inhibitor binding
- (2010) K. P. Romano et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Development of novel antiviral therapies for hepatitis C virus
- (2010) Kai Lin VIROLOGICA SINICA
- MK-7009, a Potent and Selective Inhibitor of Hepatitis C Virus NS3/4A Protease
- (2009) N. J. Liverton et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A novel HCV NS3 protease mutation selected by combination treatment of the protease inhibitor boceprevir and NS5B polymerase inhibitors
- (2009) Robert Chase et al. ANTIVIRAL RESEARCH
- Future treatment options for HCV: Double, triple, what is the optimal combination?
- (2009) Bernd Kronenberger et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- New Therapies for Hepatitis C Virus Infection
- (2009) Vincent Soriano et al. CLINICAL INFECTIOUS DISEASES
- HCV NS5B Polymerase Inhibitors
- (2009) James R. Burton et al. Clinics in Liver Disease
- The efficacy and safety of telaprevir – a new protease inhibitor against hepatitis C virus
- (2009) Ivan Gentile et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Progress towards improving antiviral therapy for hepatitis C with hepatitis C virus polymerase inhibitors. Part I: Nucleoside analogues
- (2009) Nathaniel A Brown EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Recent advances in the development of NS5B polymerase inhibitors for the treatment of hepatitis C virus infection
- (2009) Pierre L Beaulieu EXPERT OPINION ON THERAPEUTIC PATENTS
- Resistance to Direct Antiviral Agents in Patients With Hepatitis C Virus Infection
- (2009) Christoph Sarrazin et al. GASTROENTEROLOGY
- Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus-infected patients
- (2009) Simone Susser et al. HEPATOLOGY
- Viral resistance to specifically targeted antiviral therapies for hepatitis C (STAT-Cs)
- (2009) T. L. Kieffer et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Structural Basis for Resistance of the Genotype 2b Hepatitis C Virus NS5B Polymerase to Site A Non-Nucleoside Inhibitors
- (2009) Edwin H. Rydberg et al. JOURNAL OF MOLECULAR BIOLOGY
- Antiviral resistance and specifically targeted therapy for HCV (STAT-C)
- (2009) A. J. V. Thompson et al. JOURNAL OF VIRAL HEPATITIS
- Identification of Hepatitis C Virus NS5A Inhibitors
- (2009) J. A. Lemm et al. JOURNAL OF VIROLOGY
- Crystal Structure of a Novel Dimeric Form of NS5A Domain I Protein from Hepatitis C Virus
- (2009) R. A. Love et al. JOURNAL OF VIROLOGY
- Selection and Characterization of Hepatitis C Virus Replicons Dually Resistant to the Polymerase and Protease Inhibitors HCV-796 and Boceprevir (SCH 503034)
- (2008) M. Flint et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Preclinical Characteristics of the Hepatitis C Virus NS3/4A Protease Inhibitor ITMN-191 (R7227)
- (2008) S. D. Seiwert et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Characterization of resistance mutations against HCV ketoamide protease inhibitors
- (2008) X TONG et al. ANTIVIRAL RESEARCH
- HCV796: A selective nonstructural protein 5B polymerase inhibitor with potent anti-hepatitis C virus activity In Vitro, in mice with chimeric human livers, and in humans infected with hepatitis C virus
- (2008) Norman M. Kneteman et al. HEPATOLOGY
- Regulation of Hepatitis C Virion Production via Phosphorylation of the NS5A Protein
- (2008) Timothy L. Tellinghuisen et al. PLoS Pathogens
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now